ACH04 to Assess the Safety and Tolerability in Healthy Adults Subjects
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
This study intends to provide information on the safety and tolerability of repeated oral
doses of ACH04. A phase I, single-center, first in human, open-label, dose escalation study
of ACH04 to assess the safety and tolerability in healthy adults subjects is selected to best
address the study goals.